Csenge Advisory Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,515
| Closed | -$325K | – | 722 |
|
|
2024
Q2 | $325K | Sell |
3,515
-14
| -0.4% | -$1.29K | 0.02% | 506 |
|
|
2024
Q1 | $337K | Sell |
3,529
-381
| -10% | -$36.4K | 0.02% | 519 |
|
|
2023
Q4 | $298K | Sell |
3,910
-2,429
| -38% | -$185K | 0.02% | 522 |
|
|
2023
Q3 | $439K | Sell |
6,339
-2,679
| -30% | -$186K | 0.03% | 398 |
|
|
2023
Q2 | $851K | Buy |
9,018
+546
| +6% | +$51.5K | 0.06% | 245 |
|
|
2023
Q1 | $701K | Buy |
8,472
+51
| +0.6% | +$4.22K | 0.05% | 268 |
|
|
2022
Q4 | $628K | Sell |
8,421
-306
| -4% | -$22.8K | 0.05% | 294 |
|
|
2022
Q3 | $721K | Buy |
8,727
+454
| +5% | +$37.5K | 0.06% | 263 |
|
|
2022
Q2 | $787K | Sell |
8,273
-107
| -1% | -$10.2K | 0.07% | 252 |
|
|
2022
Q1 | $986K | Buy |
8,380
+1,086
| +15% | +$128K | 0.08% | 222 |
|
|
2021
Q4 | $764K | Sell |
7,294
-458
| -6% | -$48K | 0.07% | 251 |
|
|
2021
Q3 | $870K | Buy |
7,752
+458
| +6% | +$51.4K | 0.07% | 245 |
|
|
2021
Q2 | $764K | Buy |
7,294
+4,301
| +144% | +$451K | 0.07% | 252 |
|
|
2021
Q1 | $257K | Sell |
2,993
-98
| -3% | -$8.42K | 0.03% | 419 |
|
|
2020
Q4 | $282K | Sell |
3,091
-75
| -2% | -$6.84K | 0.03% | 343 |
|
|
2020
Q3 | $249K | Sell |
3,166
-55
| -2% | -$4.33K | 0.03% | 330 |
|
|
2020
Q2 | $223K | Buy |
+3,221
| New | +$223K | 0.03% | 329 |
|
|
2018
Q4 | – | Sell |
-417
| Closed | -$20K | – | 591 |
|
|
2018
Q3 | $20K | Sell |
417
-3,900
| -90% | -$187K | 0.01% | 392 |
|
|
2018
Q2 | $211K | Buy |
+4,317
| New | +$211K | 0.08% | 236 |
|